Center-Authored Papers

Filters: Author is Goodman, Phyllis J  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Chen H, Liu X, Brendler CB, Ankerst DP, Leach RJ, Goodman PJ, Lucia SM, Tangen CM, Wang L, Hsu F-C et al..  2016.  Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial.. The Prostate. 76(12):1120-1129. Abstract
Gong Z, Kristal AR, Schenk JM, Tangen CM, Goodman PJ, Thompson IM.  2009.  Alcohol consumption, finasteride, and prostate cancer risk: results from the Prostate Cancer Prevention Trial.. Cancer. 115(16):3661-9. Abstract
Price DK, Chau CH, Till C, Goodman PJ, Baum CE, Ockers SB, English BC, Minasian L, Parnes HL, Hsing AW et al..  2010.  Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trial.. The Journal of urology. 184(6):2297-302. Abstract
Figg WD, Chau CH, Price DK, Till C, Goodman PJ, Cho Y, Varella-Garcia M, Reichardt JKV, Tangen CM, Leach RJ et al..  2014.  Androgen Receptor CAG Repeat Length and TMPRSS2:ETS Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial.. Urology. Abstract
Nash SH, Schenk JM, Kristal AR, Goodman PJ, Lucia SM, Parnes HL, Thompson IM, Lippman SM, Song X, Gurel B et al..  2015.  Association between serum phospholipid fatty acids and intraprostatic inflammation in the placebo arm of the Prostate Cancer Prevention Trial.. Cancer prevention research (Philadelphia, Pa.). Abstract
Winchester DA, Till C, Goodman PJ, Tangen CM, Santella RM, Johnson-Pais TL, Leach RJ, Xu J, Zheng LS, Thompson IM et al..  2017.  Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.. The Prostate. Abstract
Price DK, Chau CH, Till C, Goodman PJ, Leach RJ, Johnson-Pais TL, Hsing AW, Hoque A, Parnes HL, Schenk JM et al..  2016.  Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.. Cancer. 122(15):2332-2340. Abstract
Wu K, Spiegelman D, Hou T, Albanes D, Allen NE, Berndt SI, van den Brandt PA, Giles GG, Giovannucci E, Goldbohm AR et al..  2016.  Associations between unprocessed red and processed meat, poultry, seafood and egg intake and the risk of prostate cancer: A pooled analysis of 15 prospective cohort studies.. International journal of cancer. Journal international du cancer. 138(10):2368-2382. Abstract
Kristal AR, Till C, Tangen CM, Goodman PJ, Neuhouser ML, Stanczyk FZ, Chu LW, Patel SK, Thompson IM, Reichardt JK et al..  2012.  Associations of Serum Sex Steroid Hormone and 5α-Androstane-3α,17β-Diol Glucuronide Concentrations with Prostate Cancer Risk Among Men Treated with Finasteride.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Gusev A, Shi H, Kichaev G, Pomerantz M, Li F, Long HW, Ingles SA, Kittles RA, Strom SS, Rybicki BA et al..  2016.  Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation.. Nature communications. 7:10979. Abstract
B
Kristal AR, Darke AK, Morris SJ, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL, Goodman GE, Minasian LM, Parnes HL et al..  2014.  Baseline Selenium Status and Effects of Selenium and Vitamin E Supplementation on Prostate Cancer Risk.. Journal of the National Cancer Institute. Abstract
Tangen CM, Goodman PJ, Till C, Schenk JM, Lucia SM, Thompson IM.  2016.  Biases in Recommendations for and Acceptance of Prostate Biopsy Significantly Affect Assessment of Prostate Cancer Risk Factors: Results From Two Large Randomized Clinical Trials.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(36):4338-4344. Abstract
C
Key TJ, Appleby PN, Travis RC, Albanes D, Alberg AJ, Barricarte A, Black A, Boeing H, Bueno-de-Mesquita BH, Chan JM et al..  2015.  Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies.. The American journal of clinical nutrition. 102(5):1142-57. Abstract
Thompson IM, Tangen CM, Goodman PJ, Lucia SM, Klein EA.  2009.  Chemoprevention of prostate cancer.. The Journal of urology. 182(2):499-507;discussion508. Abstract
Gurel B, Lucia SM, Thompson IM, Goodman PJ, Tangen CM, Kristal AR, Parnes HL, Hoque A, Lippman SM, Sutcliffe S et al..  2014.  Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Lance P, Alberts DS, Thompson PA, Fales L, Wang F, San Jose J, Jacobs ET, Goodman PJ, Darke AK, Yee M et al..  2016.  Colorectal Adenomas in Participants of the SELECT Randomized Trial of Selenium and Vitamin E for Prostate Cancer Prevention.. Cancer prevention research (Philadelphia, Pa.). Abstract
D
Ng MCY, Graff M, Lu Y, Justice AE, Mudgal P, Liu C-T, Young K, Yanek LR, Feitosa MF, Wojczynski MK et al..  2017.  Discovery and fine-mapping of adiposity loci using high density imputation of genome-wide association studies in individuals of African ancestry: African ancestry anthropometry genetics consortium.. PLoS genetics. 13(4):e1006719. Abstract
Huyghe JR, Bien SA, Harrison TA, Kang HM, Chen S, Schmit SL, Conti DV, Qu C, Jeon J, Edlund CK et al..  2018.  Discovery of common and rare genetic risk variants for colorectal cancer.. Nature genetics. Abstract
E
Hoque A, Yao S, Till C, Kristal AR, Goodman PJ, Hsing AW, Tangen CM, Platz EA, Stanczyk FZ, Reichardt JKV et al..  2015.  Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade disease.. Urology. 85(3):616-20. Abstract
Guertin KA, Grant RK, Arnold KB, Burwell L, Hartline JA, Goodman PJ, Minasian LM, Lippman SM, Klein E, Cassano PA.  2016.  Effect of long-term vitamin E and selenium supplementation on urine F2-isoprostanes, a biomarker of oxidative stress.. Free radical biology & medicine. 95:349-356. Abstract
Lippman SM, Klein EA, Goodman PJ, Lucia SM, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano MJ, Hartline JA et al..  2009.  Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).. JAMA : the journal of the American Medical Association. 301(1):39-51. Abstract
Lotan Y, Goodman PJ, Youssef RF, Svatek RS, Shariat SF, Tangen CM, Thompson IM, Klein EA.  2012.  Evaluation of Vitamin E and Selenium Supplementation for the Prevention of Bladder Cancer in SWOG Coordinated SELECT.. The Journal of urology. 187(6):2005-10. Abstract
F
Gritz ER, Arnold KB, Moinpour CM, Burton-Chase AM, Tangen CM, Probstfield JF, See WA, Lieber MM, Caggiano V, Moody-Thomas S et al..  2014.  Factors Associated with Adherence to an End-of-Study Biopsy: Lessons from the Prostate Cancer Prevention Trial (SWOG-Coordinated Intergroup Study S9217).. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Chau CH, Price DK, Till C, Goodman PJ, Chen X, Leach RJ, Johnson-Pais TL, Hsing AW, Hoque A, Tangen CM et al..  2015.  Finasteride concentrations and prostate cancer risk: results from the prostate cancer prevention trial.. PloS one. 10(5):e0126672. Abstract
Redman MW, Tangen CM, Goodman PJ, Lucia SM, Coltman CA, Thompson IM.  2008.  Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach.. Cancer prevention research (Philadelphia, Pa.). 1(3):174-81. Abstract